首页> 外文期刊>BMC Medical Informatics and Decision Making >A data-driven approach to a chemotherapy recommendation model based on deep learning for patients with colorectal cancer in Korea
【24h】

A data-driven approach to a chemotherapy recommendation model based on deep learning for patients with colorectal cancer in Korea

机译:基于深入学习对韩国结肠直肠癌患者的化疗推荐模型的数据驱动方法

获取原文
           

摘要

Clinical Decision Support Systems (CDSSs) have recently attracted attention as a method for minimizing medical errors. Existing CDSSs are limited in that they do not reflect actual data. To overcome this limitation, we propose a CDSS based on deep learning. We propose the Colorectal Cancer Chemotherapy Recommender (C3R), which is a deep learning-based chemotherapy recommendation model. Our model improves on existing CDSSs in which data-based decision making is not well supported. C3R is configured to study the clinical data collected at the Gachon Gil Medical Center and to recommend appropriate chemotherapy based on the data. To validate the model, we compared the treatment concordance rate with the National Comprehensive Cancer Network (NCCN) Guidelines, a representative set of cancer treatment guidelines, and with the results of the Gachon Gil Medical Center’s Colorectal Cancer Treatment Protocol (GCCTP). For the C3R model, the treatment concordance rates with the NCCN guidelines were 70.5% for Top-1 Accuracy and 84% for Top-2 Accuracy. The treatment concordance rates with the GCCTP were 57.9% for Top-1 Accuracy and 77.8% for Top-2 Accuracy. This model is significant, i.e., it is the first colon cancer treatment clinical decision support system in Korea that reflects actual data. In the future, if sufficient data can be secured through cooperation among multiple organizations, more reliable results can be obtained.
机译:临床决策支持系统(CDSSS)最近引起了注意力,作为最小化医疗错误的方法。现有的CDSS是有限的,因为它们不反映实际数据。为了克服这一限制,我们提出了一种基于深度学习的CDS。我们提出结直肠癌化疗推荐(C3R),是一种深度学习的化疗推荐模型。我们的模型可提高现有的CDSS,其中基于数据的决策不受欢迎。 C3R配置为研究在GACHON GIL MEDICE CENTER COMETCECTION收集的临床数据,并根据数据推荐适当的化疗。为了验证该模型,我们将治疗的一系列综合性癌症网络(NCCN)指导,代表性癌症治疗指南,以及GACHON GIL MEDICAL CENTER的结直肠癌治疗方案(GCCTP)的结果。对于C3R模型,对NCCN指南的治疗一致性率为70.5%,最高1精度为84%,最精度为84%。对于前1个精度,GCCTP的治疗率为57.9%,最高2精度为77.8%。该模型很重要,即,它是韩国的第一个结肠癌治疗临床决策支持系统,反映了实际数据。将来,如果通过多个组织之间的合作可以保护足够的数据,可以获得更可靠的结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号